chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Information has been received from a physician concerning a patient (gender and age not reported) who was vaccinated with a dose of ZOSTAVAX. The patient experienced injection site pain. The patient said "ouch, it bites!". The outcome was not reported. Additional information has been requested.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a 81 year old female with hypertension who on 22-AUG-2007 was vaccinated with ZOSTAVAX for prevention of shingles. Concomitant therapy included blood pressure medication (unspecified). On 24-AUG-2007 the patient experienced bumps on her left thigh. The patient's bumps on her left thigh persisted. No Further information is expected.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a female with history of chemotherapy who was vaccinated with ZOSTAVAX. Subsequently the patient experienced zoster on the face. Additional information has been requested. 12/21/07 This is in follow-up to report(s) previously submitted on 9/24/2007. Initial and follow up information has been received from a physician concerning a 60 year old female with a history of chemotherapy and breast cancer who on 22-JAN-2007 was vaccinated SC in the right arm with a 0.65 ml first dose of ZOSTAVAX (Oka/Merck) (Lot#652935/0621F). There was no illness at the time of vaccination. On 14-AUG-2007 the patient developed zoster on the face approximatly 10 lesions at the right trigeminal nerve. There was no rash at the injection site or elsewhere within 42 days of vaccination. The patient had pain which was a level 4 on a scale of 0 (least) to 10 (most). The patient had no other systemic symptoms. There was no recent exposure to chicken pox or herpes zoster. A DFA was not done. A specimen was not collected for PCR. A photo was not taken. On 29-AUG-2007 the patient recovered. No further information was provided. There was no product quality complaint involved. The patient had no adverse events following prior vaccination. Additional information is not expected.
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Ophthalmological examination
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with ZOSTAVAX. "A few months later", the patient was diagnosed with shingles. He also saw a opthamologist fro evaluation. Shingles was fully resolved on 22-JUN-2007. Follow-up was received from a registered nurse (R.N). This is one of several reports from the same source. Additional information has been requested.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 65 year old male who on 18-JUL-2007 was vaccinated with ZOSTAVAX. There was no concomitant medication. On approximately 25-JUL-2007 the patient developed shingles. The patient's shingles persisted. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Inappropriate schedule of drug administration, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a 51 year old female who in approximately August 2007, was vaccinated with ZOSTAVAX, lot # 656861/0329U). The patient called the office a few hours after she was vaccinated, in approximately August 2007 and reported that she experienced a fever and headache. As of 24-AUG-2007 the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a patient who on 10-AUG-2007 was inadvertently administered ZOSTAVAX instead of VARIVAX. There was no product confusion. The patient was not experiencing any known symptoms. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Induration
Clinical narrative: Information has been received from a physician concerning a male who was vaccinated with a single dose of ZOSTAVAX. After the patient received the dose of zoster vaccine, he developed a knot on his arm the size of a golf ball. No other information was reported. This is one of several reports from the same source. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a male (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with Zostavax (Oka/Merck, lot # 657558/0461U) instead of Varivax (MSD).  Subsequently, no adverse experiences have been reported.  Unspecified medical attention was sought.  This is one of several reports received from the same source.  Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a male (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with ZOSTAVAX (lot # 657558/0461U) instead of varicella virus vaccine live (MSD). Subsequently, no adverse experiences have been reported. Unspecified medical attention was sought. The nurse reported in follow-up thath the packaging for the ZOSTAVAX and Varicella virus live (MSD) was similar and the 2 vaccines were stored in the same freezer. The Varicella virus vaccine live (MSD) had run out and the ZOSTAVAX picked up mistakenly. The nurse hoped to avoid this event in the future. There have been positive results noted from the parents of the vaccinated child.This is one of several reports received from the same source. Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with Zostavax (Oka/Merck, lot # 657558/0461U) instead of Varivax (MSD).  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  This is one of several reports received from the same source.  Additional information has been requested. The nurse reported in follow-up that the packaging for the ZOSTAVAX and VARIVAX was similar and the 2 vaccines were stored in the same freezer. The VARIVAX had run and the ZOSTAVAX was picked up mistakenly. The nurse hoped to avoid this event in the event. There have been positive results noted from the parents of the vaccinated child. Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with ZOSTAVAX (lot # 657558/0461U) instead of varicella virus vaccine live (MSD). Subsequently no adverse experiences have been reported. Unspecified medical attention was sought. This is one of several reports received from the same source. Additional information has been requested. The nurse reported in follow-up that the packaging for the ZOSTAVAX (Merck) and VARIVAX was similar and the 2 vaccines were stored in the same freezer. The VARIVAX vaccine had run out and the ZOSTAVAX vaccine (Merck) was picked mistakenly. The nurse hoped to avoid this event in the future. There have been positive results noted from the parents of the vaccinated child. This is one of several reports received from the same source. Additional infromation is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with Zostavax (Oka/Merck, lot # 657558/0461U) instead of Varivax (MSD).  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  This is one of several reports received from the same source.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 9/24/2007.  Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with ZOSTAVAX (Merck), lot # 657558/0461U) instead of varicella virus vaccine live (MSD).  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  The nurse reported in follow-up that the packaging for the ZOSTAVAX (Merck) and VARIVAX was similar and the 2 vaccines were stored in the same freezer.  The VARIVAX had run out and the ZOSTAVAX (Merck) was picked up mistakenly.  The nurse hoped to avoid this event in the future.  There have been positive results noted from the parents of the vaccinated child.  This is one of several reports received from the same source.  Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with Zostavax (Oka/Merck, lot # 657558/0461U) instead of Varivax (MSD).  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  This is one of several reports received from the same source.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 9/24/2007.  Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with ZOSTAVAX (Merck), (lot # 657558/0461U) instead of VARIVAX.  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  The nurse reported in follow-up that the packaging for the ZOSTAVAX (Merck) and VARIVAX was similar and the 2 vaccines were stored in the same freezer.  The VARIVAX had run out and the ZOSTAVAX (Merck) was picked up mistakenly.  The nurse hoped to avoid this event in the future.  There have been positive results noted from the parents of the vaccinated child.  This is one of several reports received from the same source.  Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: This is in follow-up to report (s) previously submitted on 9/24/2007. Information has been received from a licensed practical nurse concerning a female (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with Zostavax (Oka/Merck, lot # 657558/04161U) instead of Varivax (MSD).  Subsequently no adverse experiences have been reported.  Unspecified medical attention was sought.  The nurse reported in follow-up that the packaging for the ZOSTAVAX (Oka/Merck) and varicella virus vaccine live (MSD) was similar and the 2 vaccines were stored in the same freezer. The varicella virus vaccine live (MSD) had run out and the ZOSTAVAX (Oka/Merck) was picked up mistakenly. The nurse hoped to avoid this event in the future. There have been positive results noted from the parents of the vaccinated child. This is one of several reports received from the same source.  Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure, Eye burns, Eye disorder, Vision blurred
Clinical narrative: Information has been received from a female, who on 06-JUL-2007 was exposed to ZOSTAVAX. The patient, a caregiver for someone receiving ZOSTAVAX (WAES# 0707USA01060) lifted up the sleeve of the person being vaccinated. When giving the vaccination the tech pulled out the needle and the vaccination "flew" into her eye. She had to go to urgent care. She had a film over her eye for 3 days, she stated that could not see, it burned, and it "doesn't make tears like it used to". She stated that "this was money out of her pocket" as she is the caregiver and not the patient. She felt that the costs she incurred were not her responsibility and what scared her is that "no one knew anything about side effects because it was supposed to be brand new." No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from an other health professional concerning 2 adults who were accidentally vaccinated with Zostavax (Oka/Merck) instead of Varivax (MSD).  The physician reported that the vaccines looked alike and were labeled almost identically.  No adverse events were reported.  Additional information is not expected.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician and registered nurse concerning a patient who on an unspecified date was vaccinated with a dose of Zostavax (Oka/Merck) instead of Varivax (Oka/Merck) (MSD).  There were no known symptoms reported.  The incident was "due to human error".  There was no further information provided.  There was no product quality complaint involved.  This is one of several reports from the same source.  Additional information is not expected.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician and registered nurse concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX instead of VARIVAX. There were no known symptoms reported. The incident was "due to human error". There was no further information provided. There was no product quality complaint involved. This is one of several reports from the same source. Additional information is not expected.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Immediate post-injection reaction, Inflammation, Local reaction, Pain
Clinical narrative: Information has been received from a 54-year-old white female consumer licensed practical nurse (L.P.N.) with allergies to CECLOR, morphine, DEMEROL, codeine, TEQUIN and a history of herpes zoster through secondary exposure (WAES# 0611USA01550) who on 09-AUG-2007 in the PM was vaccinated in the left arm with a first dose of ZOSTAVAX (lot# 658207/0883U). Immediately, on 09-AUG-2007 the patient experienced a local reaction which included a large, red inflamed area that was hot and painful and a rash. The patient was treated with BENADRYL, ice and CATAFLAM. The outcome is reported as ongoing and recovered. It is also reported that the patient was experienced an unspecified adverse event from a vaccination in 1994 with a first dose of PNEUMOVAX 23. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Reaction to previous exposure to any vaccine, Skin warm
Clinical narrative: Information has been received from a 54-year-old white female consumer licensed practical nurse (L.P.N.) with allergies to CECLOR, morphine, DEMEROL, codeine, TEQUIN and a history of herpes zoster through secondary exposure (WAES# 0611USA01550) who on 09-AUG-2007 in the PM was vaccinated in the left arm with a first dose of ZOSTAVAX (lot# 658207/0883U). Immediately, on 09-AUG-2007 the patient experienced a local reaction which included a large, red inflamed area that was hot and painful and a rash. The patient was treated with BENADRYL, ice and CATAFLAM. The outcome is reported as ongoing and recovered. It is also reported that the patient was experienced an unspecified adverse event from a vaccination in 1994 with a first dose of PNEUMOVAX 23. Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: TTOX, VARZOS
Symptoms: Rash papular, Rash pruritic
Clinical narrative: Information has been received from a registered nurse concerning her husband a 62 year old male consumer with a history of penicillin allergy and no pertinent medical history who on 26-JUL-2007 was vaccinated subcutaneously with an "appropriate dose" of Zostavax (Oka/Merck).  Concomitant therapy included tetanus toxoid, LOTENSIN and LIPITOR.  On 11-AUG-2007 or 12-AUG-2007 the patient developed a widespread rash on his upper thighs, forearms, knees, and lower legs.  The rash is described as a papular-like rash, itchy, but not painful.  She does not feel that her husband has developed shingles, but possibly chicken pox.  The rash was no longer spreading.  At the time of this report the patient had not yet seen his physician, but it was reported that medical attention was sought.  No lab studies were performed.  No further information was provided.  There was no product quality complaint involved.  Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dehydration, Full blood count normal, Headache, Laboratory test normal, Nausea
Clinical narrative: Information has been received from a nurse practitioner concerning an 18 year old female with conjunctivitis at the time of vaccination who on 11-JUL-2007 was vaccinated intramuscularly with a 0.5 ml first dose of Gardasil (Lot #654535/0960F). There was no concomitant medication. On 13-JUL-2007 the patient developed a headache, nausea, vomiting and dehydration. The patient was evaluated in the emergency room and treated with unspecified intravenous fluids. Blood chemistry and complete blood count were within normal limits. Subsequently, the patient recovered. The physician considered headache, nausea, vomiting, and dehydration to be other important medical events. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Vomiting
Clinical narrative: Information has been received from a nurse practitioner concerning an 18 year old female with conjunctivitis at the time of vaccination who on 11-JUL-2007 was vaccinated intramuscularly with a 0.5 ml first dose of Gardasil (Lot #654535/0960F). There was no concomitant medication. On 13-JUL-2007 the patient developed a headache, nausea, vomiting and dehydration. The patient was evaluated in the emergency room and treated with unspecified intravenous fluids. Blood chemistry and complete blood count were within normal limits. Subsequently, the patient recovered. The physician considered headache, nausea, vomiting, and dehydration to be other important medical events. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Syncope
Clinical narrative: Information has been received from a nurse concerning a 14 year old female who on approximately 31-AUG-2007 was vaccinated with a 0.5 ml first dose of Gardasil. It was reported that after the patient received her first dose of Gardasil she experienced a minor seizures and fainting. Unspecified medical attention was sought. Subsequently, the patient recovered. Upon internal review, minor seizures was considered to be other important medical event. No further information is available.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Haematochezia, Occult blood positive
Clinical narrative: Information has been received from a physician concerning a 2 month old female with no pertinent medical history and no known drug reactions/allergies who about two weeks ago (10-SEP-2007) was vaccinated with first 2 ml oral dose of Rotateq. Concomitant therapy included Pediarix, PedvaxHIB and Prevnar. Subsequently within a few days of vaccination, the patient experienced diarrhea for about 10 days with blood in stool. Her stools were tested in the office and were positive for occult blood. A stool specimen was collected for the lab for blood and results are pending. The blood in stool resolved after a few days but the patient's diarrhea persisted. The patient was seen in the physician's office. The patient required no treatment and continued with routine feedings. Upon internal review blood in the stool was considered to be an other important medical event. There was no product quality complaint involved. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Angioedema
Clinical narrative: Child received Tdap, Varicella, Menactra and HPV #1 on 09/11/07. On 09/13/07 she woke up with angioedema of face. There was no difficulty breathing or swallowing. There was no seafood or nut ingestion. She took Motrin the night before and was hospitalized. Received IV steroids and discharged home the next day. 10/15/07-records received for DOS 9/13-9/14/07. DC DX: Angioedema. On day of admission noticed face swollen, with significant swelling of lips and lower face causing disfiguration and drooling.  Self treated with Motrin. DC instructions include avoid Motrin and follow up with allergist
Age: 83.0
Sex: F
Vaccine: TDAP
Symptoms: Inappropriate schedule of drug administration, No adverse reaction, Wrong drug administered
Clinical narrative: Adacel (Tdap) given to client over age 64 no adverse effects known.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Childs arms became reddened, some swelling and tenderness extending beyond shot.
Age: 16.0
Sex: F
Vaccine: HEPA, MEN
Symptoms: Convulsion, Loss of consciousness, Pallor, Skin discolouration
Clinical narrative: Lost consciousness, convulsed 20-30 seconds, layed down with wet paper towel on head started to leave and lost consciousness again while walking. Very grey in color. No color to lips. Sat down in chair. Convulsed. Lay down with towel, Coke < 5 minutes.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site cellulitis
Clinical narrative: Right thigh cellulitis at injection site. Treated with 10 day course of antibiotic - Keflex and resolved.
Age: 15.0
Sex: M
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Body temperature increased, Dehydration, Dizziness, Immunisation reaction, Urticaria
Clinical narrative: 24 hours after vaccines went to on-call doctor temp 101, dizzy, dehydrated, urticaria rash left cheek, b/p lying 113/55 sit 105/56 stand 98/50 probable vaccine reaction vs mild viral illness.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Dizziness, Headache, Loss of consciousness
Clinical narrative: Received vaccine on Friday 09/21/2007. Reported feeling dizzy, HA, and passing out on Saturday 09/22/07.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Urticaria
Clinical narrative: Patient reports 4 days after receiving Tdap vaccine she began to break out in hives. She has required several office/ER visits. No reported changes in other habits - no new exposures other than vaccine still has episodic urticaria 6 1/2 months later.
Sex: F
Vaccine: HEP
Symptoms: Cellulitis
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of cellulitis in a female subject of unspecified age and gender who was vaccinated with Engerix B, GlaxoSmithKline for prophylaxis. The reporter indicated that it was the GSK brand but was unable to confirm the brand name. On an unspecified date the subject received unspecified dose of Engerix B (unknown). At an unspecified time after vaccination with Engerix B, the subject experienced cellulitis. The reporter was not certain about the site of the cellulitis. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Seen 9/19/07 for 8 year old WCV received flu vaccine woke up 9/20/07 with red, swollen, hot arm at injection site. Diagnosed with Cellulitis treated with Keflex.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Urticaria
Clinical narrative: Erythema to injection site (left deltoid) progressing to urticaria and hives along left arm, left chest, left side of back treatment: Kenalog 40mg IM, Benadryl 25mg PO.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Rash, Rash papular
Clinical narrative: Rash began on neck - spreading on arm and face. Has appropriately 15 papules total. Symptomatic treatment at home.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Arthritis, Back pain, Secondary transmission
Clinical narrative: This event occurred to the parent unclear if any relationship to vaccine. On 7/9/07 child received Rotateq, DTaP, IPV, PCV7, Hib-Hep B. On 7/16/07 Dad developed acute arthritis both knees, and then toes. (He also had some back pain around this time). He has been suffering greatly from this arthritis, which is thought to be reactive. (He was previously healthy; no co-worker or other contacts with gastroenteritis when to be some ill in July).
Age: 25.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Diarrhoea, Dizziness, Malaise, Nausea
Clinical narrative: Did not feel well all day, nauseous - dizzy and diarrhea - all sx subsided in 5 days.
Age: 25.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Nausea
Clinical narrative: Did not feel well all day, nauseous - dizzy and diarrhea - all sx subsided in 5 days.
Age: 0.4
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Agitation, Crying, Drug intolerance, Insomnia, Irritability
Clinical narrative: Fever 103, fussy, crying, decreased sleep, went to ER 9/1/07, dx with UTI and given Bactrim. Came to doctor office 9/3/07. Dx: Drug reaction vs. Early Stevens Johnson vs. Kawasaki Disease. Pt admitted to hospital x 7 days. Diagnosed with Kawasaki, peeling hand, feet, nail bed.   10/1/07 Received vax record which confirms RO dose & lot # as reported.  10/2/07 Reviewed hospital medical records which reveal patient experienced rash, fever, runny nose, diarrhea, conjunctival injection, oral erythema, cracked lips, swollen hands & feet & fussiness.  Admitted 9/3-9/8/2007.  Seen in ER for UTI & given IM & oral antibiotic on 8/30 & developed rash & fussiness on 9/1.  Returned to ER for tx w/antibiotic, steroids & antihistamine.  D/C to home.  No response to treatment & seen by pcp 9/3 who direct admitted.  Continued fever x 5 days.  Dermatology & cardiology consults done.  Tx w/IVIG & ASA & improved.  D/C to home on continued ASA & w/cardiac f/u.   FINAL DX: Kawasaki Disease.
Age: 0.4
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Kawasaki's disease, Pyrexia, Skin exfoliation, Urinary tract infection
Clinical narrative: Fever 103, fussy, crying, decreased sleep, went to ER 9/1/07, dx with UTI and given Bactrim. Came to doctor office 9/3/07. Dx: Drug reaction vs. Early Stevens Johnson vs. Kawasaki Disease. Pt admitted to hospital x 7 days. Diagnosed with Kawasaki, peeling hand, feet, nail bed.   10/1/07 Received vax record which confirms RO dose & lot # as reported.  10/2/07 Reviewed hospital medical records which reveal patient experienced rash, fever, runny nose, diarrhea, conjunctival injection, oral erythema, cracked lips, swollen hands & feet & fussiness.  Admitted 9/3-9/8/2007.  Seen in ER for UTI & given IM & oral antibiotic on 8/30 & developed rash & fussiness on 9/1.  Returned to ER for tx w/antibiotic, steroids & antihistamine.  D/C to home.  No response to treatment & seen by pcp 9/3 who direct admitted.  Continued fever x 5 days.  Dermatology & cardiology consults done.  Tx w/IVIG & ASA & improved.  D/C to home on continued ASA & w/cardiac f/u.   FINAL DX: Kawasaki Disease.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Convulsion, Immediate post-injection reaction
Clinical narrative: MMR + Varicella vaccine administered at 1000 a.m. and had seizure 60 seconds later. Child admitted to hospital and had seizure approximately 1600. Child transferred to another hospital.  10/05/2007 MR received for DOS 9/27-29/2007 for DX of Acute seizure after receiving MMR vaccination.  Immediately after receiving MMRV child cried and then eyes rolled back and jerking was noted in his arms. Episode lasted several minutes.  Transfered by EMS to local ER and admitted for observation.  That pm had another episode of seizure like activity with eyes rolling back and stiffness, lasting 30-40 sec. Sleepy post-ictal.  Transfered to current facility where another seizure occured similar to the first with additional staring episode noted.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Erythema, Pain in extremity, Rash generalised, Swelling
Clinical narrative: Swelling and redness with pain to both hands also rash to body; symptoms started at 7:00pm - 9/27/07. Treatment: Benadryl 25mg tab 1 PO q hour.
Age: 0.2
Sex: F
Vaccine: RV5
Symptoms: Culture stool, Culture stool negative, Diarrhoea, Faeces discoloured, Mucous stools
Clinical narrative: Rotateq given 8-9-07 about 2 1/2 weeks later started with watery green mucousy stool. Lasted until 9-16-07. Stool culture - done. All negative. Better now - stool forming some. No more Rotateq.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Body temperature increased, Pain
Clinical narrative: Patient states temperature 102, achy all over starting at 2:30am 9/20/07. Temperature at 1:30pm 99.8.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Herpes zoster, Hypoaesthesia, Muscle spasms, Pain
Clinical narrative: Received shingles vaccine Jan 26, 2007. First shingles rash 08/07/07. Visited doctor 08/13 received Zovirax cream prescription. Severe spasms in area and pain. Acupuncture treatments seemed to ease pain. Still have some rash and numbness, burning, itching 6 weeks later.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Received shingles vaccine Jan 26, 2007. First shingles rash 08/07/07. Visited doctor 08/13 received Zovirax cream prescription. Severe spasms in area and pain. Acupuncture treatments seemed to ease pain. Still have some rash and numbness, burning, itching 6 weeks later.
Age: 4.0
Sex: U
Vaccine: IPV, MMRV, TDAP
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling developed at injection site of DTaP within 24 hours of injection treated for cellulitis.
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Erythema, Induration, Oedema peripheral, Pharyngolaryngeal pain, Pruritus
Clinical narrative: Started with itchy sensation on 9/18/07 and noted swelling on 9/19/07. Sore throat 1 day swelling left upper outer arm 5" x 3" with an indurated area 2" x 3" with an indurated area 2" x 1". Further redness on the forearm, 4 x 3 1/2". Rise of temp upper arm.
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Skin warm
Clinical narrative: Started with itchy sensation on 9/18/07 and noted swelling on 9/19/07. Sore throat 1 day swelling left upper outer arm 5" x 3" with an indurated area 2" x 3" with an indurated area 2" x 1". Further redness on the forearm, 4 x 3 1/2". Rise of temp upper arm.
Age: 0.37
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration, Unevaluable event
Clinical narrative: None at this time.
Age: 0.1
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Culture stool negative, Diarrhoea
Clinical narrative: Patient has watery/loose stool 3-4x/day since 8/27/06 vaccination ? Rotavirus adverse effect.
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Headache, Oedema, Pain, Pruritus
Clinical narrative: Local erythema, edema, pain, itching and HA. Benadryl 250mg PO q4-6 hours PRN, Tylenol PRN. Cool compresses to site.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Injection site swelling, induration redness. Treated with Keflex for possible secondary infection.
Age: 76.0
Sex: M
Vaccine: UNK
Symptoms: Cough, Pyrexia, Similar reaction on previous exposure to drug, Throat tightness, Tremor
Clinical narrative: Fever 102, shaking chills, throat clogged, cough 48 hour after vaccine (occurred after flu shot years ago).
Age: 5.0
Sex: M
Vaccine: PPV
Symptoms: Heat therapy, Oedema peripheral, Pain in extremity
Clinical narrative: Client c/o pain starting at upper arm and then in the fingers and mother noticed arm swollen the next day. Mom said she did apply warm compress then visited private doctor temperature is normal.
Age: 13.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Client c/o pain starting at injection site 9/26/07 but get more swollen and painful 9/27/07. Applied with compress x 1. Seen by private MD had fever x 2 days receive treatment of Zinnat 212 500mg and Motrin PRN. Temp normal.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Erythema, Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Generalized body aches, fever, chills with erythema, edema and warmth at injection site within 24 hours of injection.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Pain, Pyrexia
Clinical narrative: Generalized body aches, fever, chills with erythema, edema and warmth at injection site within 24 hours of injection.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling and redness at site of vaccination 3cm x 3cm.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Pruritus, Pyrexia, Skin warm
Clinical narrative: Had fever on 9/27/07 redness 10 x 10 itching. Warm to touch left upper arm.
Age: 8.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Oedema peripheral, Pain
Clinical narrative: Left arm swelling, redness, pain
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Patient with 2 Varivax shots 11-7-02 and 2-12-07. Now with chickenpox approximately 30 lesions.
Age: 24.0
Sex: F
Vaccine: MMR, UNK
Symptoms: Blood pressure decreased, Dizziness, Gaze palsy, Heart rate decreased, Hyperhidrosis
Clinical narrative: During MMR administration: c/o dizziness after (immediate): patient stiffened, head back, eyes rolled back, pale, sweaty, stopped breathing, urination in clothing. Recovered on own after 15 second. Decrease BP decrease HR given O2 via nasal canula.
Age: 24.0
Sex: F
Vaccine: MMR, UNK
Symptoms: Musculoskeletal stiffness, Pallor, Respiratory arrest, Urinary incontinence
Clinical narrative: During MMR administration: c/o dizziness after (immediate): patient stiffened, head back, eyes rolled back, pale, sweaty, stopped breathing, urination in clothing. Recovered on own after 15 second. Decrease BP decrease HR given O2 via nasal canula.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Contusion, Injection site erythema, Injection site induration
Clinical narrative: 21mm x 31mm erythema/induration without tenderness at site, 11 days after MMR vaccine bruising proceeded erythema
Age: 49.0
Sex: F
Vaccine: HEP, HEPA, MMR
Symptoms: Arthralgia, Musculoskeletal pain
Clinical narrative: Patient has history of Measles and Mumps disease as noted and previous Rubella shot after delivering her son. She needed MMR for 1st responder class. Has had prolonged joint pain starting approximately a week after the shot. Hands, fingers, knees, hips right. Both shoulders very painful at times. Fingers feel creeky and not yet resolved a month after shot.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Breast feeding, Crying, Irritability, Musculoskeletal stiffness, Screaming
Clinical narrative: On 7-20-07 He started vomiting appropriately 10-12x/ day. No diarrhea still was vomiting on 7/22 and started screaming and crying inconsolably. His abdomen moved get tight and extremities, would get stiff. Had Pedialyte for 2 feeding vomiting decrease but still fussy and irritable. By 7-23-07 was keeping 1/2str and Full str breast milk down and vomiting had stopped, but was still irritable.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Vomiting
Clinical narrative: On 7-20-07 He started vomiting appropriately 10-12x/ day. No diarrhea still was vomiting on 7/22 and started screaming and crying inconsolably. His abdomen moved get tight and extremities, would get stiff. Had Pedialyte for 2 feeding vomiting decrease but still fussy and irritable. By 7-23-07 was keeping 1/2str and Full str breast milk down and vomiting had stopped, but was still irritable.
Age: 1.0
Sex: F
Vaccine: HEPA, PNC, VARCEL
Symptoms: Blister, Cellulitis, Erythema, Reaction to preservatives
Clinical narrative: Seen in office 8/27/07 for 12 month WCV received Varivax and Prevnar in right thigh, Hep A in left thigh. Seen again 9/6/07 for a few day history of blister and redness on right diagnosis with reaction to Varivax with mild cellulitis treated with Augmentin.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Received Varivax booster on 9/19/07, on 9/20/07 patient's arm around injection site was red, itchy, and warm to touch (large area). Patient evaluated in office.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Mass
Clinical narrative: Egg sized reddened hardened knot to left deltoid area.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Headache, Lethargy, Neck pain, Pyrexia
Clinical narrative: Received shots 1 week ago woke up this morning stated headache, neck ache, thas fever. States is spitting a little lethargic - but dose answer questions. Fever 97.6 - now. MMR, IPV4, DTAP5
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Blood test, Feeling hot, Fluid replacement, Gaze palsy, Infection
Clinical narrative: Interpreter used Mother stated as follows: "Vaccine given in am. At 230pm was running a fever (temperature not actually eval) felt hot, was quiet and sad, sleepy. At 1030pm was feverish, Motrin, 1 dropper was administered 15 minutes later had seizure "shaking, eyes rolling back lasted 10-15 minutes. Took child to hospital ER. Was told child had infection in nose. Child was given IV fluids. Prescribed medication 1 tsp BID for 14 days.
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Pyrexia, Somnolence, Tremor, X-ray
Clinical narrative: Interpreter used Mother stated as follows: "Vaccine given in am. At 230pm was running a fever (temperature not actually eval) felt hot, was quiet and sad, sleepy. At 1030pm was feverish, Motrin, 1 dropper was administered 15 minutes later had seizure "shaking, eyes rolling back lasted 10-15 minutes. Took child to hospital ER. Was told child had infection in nose. Child was given IV fluids. Prescribed medication 1 tsp BID for 14 days.
Age: 6.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Induration
Clinical narrative: Patient received a Varicella immunization and a Hepatitis B immunization in her left upper arm on 9-20-07. She developed a 5.5cm by 2.5cm area of induration 21 hours after administration of immunizations on left upper arm that resolved within 72 hours with Benadryl.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Unevaluable event
Clinical narrative: See picture
Age: 2.0
Sex: M
Vaccine: DTAPH, HIBV, MMR, VARCEL
Symptoms: Cold compress therapy, Erythema, Induration
Clinical narrative: 1cc induration red spot on R 47 cool compress, Tylenol PRN, Mecklings red spot
Age: 40.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness, Flushing
Clinical narrative: Approximately 215pm 9/19/07 c/o flushed, light-headed, dizzy, after 30 minutes. C/O "not being able to get deep breath." Tx - lying down, resting. 430pm Mother called again. Feeling slightly better.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV, MMR
Symptoms: Rash generalised
Clinical narrative: Patient received DTaP, Hib and MMR on 9/18/07; mom noticed rash on 9/22/07 at approximately 730pm - Head to toe.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Pyrexia
Clinical narrative: Fever noted after vaccination fever 100.6 - 101.6 (r).
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Computerised tomogram normal, Dysphagia, Guillain-Barre syndrome, Muscular weakness, Myalgia
Clinical narrative: Received Menactra vaccine 8/22/2007. Presented at student health on 9/18/07 with c/o muscle pain and intermittent tingling in extremeties.  Symptoms persisted but unchanged during visits of 9/19/07, 9/20/07 and 9/21/07.  Called and c/o weakness in legs and difficulty swallowing on 9/24/07.  Sent to ER-released same day- dx with neck sprain.  Presented to student health services again on 9/25/07 with increased weakness, changes in neuro exam.  Admitted to hospital the same day.  Diagnosed with Guillain- Barre.  Remains hospitalized and undergoing treatment currently.    11/19/2007 D/C Summary received for DOS 9/25-10/01/2007 with D/C DX: Guillain-Barre syndrome. Pt presented with 10 day hx of lower extremity weakness. Neurology and ID consults done. Started on IVIG.  Steady but gradual improvement in strength.  D/c with home PT and OT  Per 60 day follow up: Continues with PT/OT on an outpatient basis.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Neck injury, Paraesthesia, Spinal X-ray normal
Clinical narrative: Received Menactra vaccine 8/22/2007. Presented at student health on 9/18/07 with c/o muscle pain and intermittent tingling in extremeties.  Symptoms persisted but unchanged during visits of 9/19/07, 9/20/07 and 9/21/07.  Called and c/o weakness in legs and difficulty swallowing on 9/24/07.  Sent to ER-released same day- dx with neck sprain.  Presented to student health services again on 9/25/07 with increased weakness, changes in neuro exam.  Admitted to hospital the same day.  Diagnosed with Guillain- Barre.  Remains hospitalized and undergoing treatment currently.    11/19/2007 D/C Summary received for DOS 9/25-10/01/2007 with D/C DX: Guillain-Barre syndrome. Pt presented with 10 day hx of lower extremity weakness. Neurology and ID consults done. Started on IVIG.  Steady but gradual improvement in strength.  D/c with home PT and OT  Per 60 day follow up: Continues with PT/OT on an outpatient basis.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Asthenia, Electromyogram, Guillain-Barre syndrome, Immunoglobulins, Motor dysfunction
Clinical narrative: Received Menactra vaccine 8/22/2007. Presented at student health on 9/18/07 with c/o muscle pain and intermittent tingling in extremeties.  Symptoms persisted but unchanged during visits of 9/19/07, 9/20/07 and 9/21/07.  Called and c/o weakness in legs and difficulty swallowing on 9/24/07.  Sent to ER-released same day- dx with neck sprain.  Presented to student health services again on 9/25/07 with increased weakness, changes in neuro exam.  Admitted to hospital the same day.  Diagnosed with Guillain- Barre.  Remains hospitalized and undergoing treatment currently.    11/19/2007 D/C Summary received for DOS 9/25-10/01/2007 with D/C DX: Guillain-Barre syndrome. Pt presented with 10 day hx of lower extremity weakness. Neurology and ID consults done. Started on IVIG.  Steady but gradual improvement in strength.  D/c with home PT and OT  Per 60 day follow up: Continues with PT/OT on an outpatient basis.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Nerve conduction studies, Paraesthesia
Clinical narrative: Received Menactra vaccine 8/22/2007. Presented at student health on 9/18/07 with c/o muscle pain and intermittent tingling in extremeties.  Symptoms persisted but unchanged during visits of 9/19/07, 9/20/07 and 9/21/07.  Called and c/o weakness in legs and difficulty swallowing on 9/24/07.  Sent to ER-released same day- dx with neck sprain.  Presented to student health services again on 9/25/07 with increased weakness, changes in neuro exam.  Admitted to hospital the same day.  Diagnosed with Guillain- Barre.  Remains hospitalized and undergoing treatment currently.    11/19/2007 D/C Summary received for DOS 9/25-10/01/2007 with D/C DX: Guillain-Barre syndrome. Pt presented with 10 day hx of lower extremity weakness. Neurology and ID consults done. Started on IVIG.  Steady but gradual improvement in strength.  D/c with home PT and OT  Per 60 day follow up: Continues with PT/OT on an outpatient basis.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Idiopathic thrombocytopenic purpura, Immunoglobulins, Platelet count decreased
Clinical narrative: Patient developed Idiopathic thrombocytopenia within 30 days of receiving the MMR vaccine. He has required immunglobulin multiple times. At 16 months of age he continues to have low platelet counts, is at risk for bleeding diathesis.  11/2/07 Reviewed hospital medical records which reveal patient experienced progressive bruising over 3 day period on bilateral LEs.  Developed additional bruising over arms, trunk & nose w/nosebleed. Admitted 6/25-6/28/07.  Exam revealed petechiae of hard palate as well as multiple ecchymosis & petechaie.  Received IVIG x 2 doses.  Improved & d/c to home w/helmet, f/u labs & hematology clinic. FINAL DX: Immune thrombocytopenic purpura.
Age: 17.0
Sex: F
Vaccine: HPVX
Symptoms: Dizziness
Clinical narrative: PATIENT WAS DIZZY FOR 3 DAYS AFTER SHE RECEIVED 2ND HPV VACCINE
Age: 17.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: No adverse reaction.  Patient received an Adult dose of Hepatitis A vaccine in error.  Should have received a Pediatric Dose of Hepatitis A
Age: 17.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: None.  Adult dose given in error.  Should have received a pediatric dose.
Age: 1.0
Sex: F
Vaccine: HBHEPB, HEPA, MMRV
Symptoms: Cellulitis, Pyrexia, Rash, Varicella, Varicella post vaccine
Clinical narrative: Received ProQuad on 9/17/07 and developed rash on 9/23/07 per mom.  Was seen on 9/24/07 and diagnosed with varicella.  Child returned on 9/26/07 with fever, varicella and cellulitis.  Now being treated with Keflex.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema, Pain
Clinical narrative: Erythema, Edema, Pain- Benadryl, Zantac, Prednisone.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pruritus, Injection site swelling, Swollen tongue
Clinical narrative: Redness, Swelling, Itching at injection site immidiately after injection that lasted 3-4 days. Tongue swelling that started 2 days after vaccine administered and lasted 1-2 days.
Age: 17.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Feeling cold, Tremor
Clinical narrative: Patient is experiencing trembling in the upper torsal 2 hours after given the fluvirin vaccine.  Patient is experiencing some chills and cold.
Age: 10.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Mother called the health department yesterday to report that patient's right arm was reddened, swollen, warm to touch, and painful at the site of the Varivax that was administered on 9/24.  The reaction did not appear until yesterday morning.  Denies fever.  She was referred to pediatrician for advice.  PCP would not give advice over the phone without an appointment with the physician.   Patient is a student.  A nurse there looked at the site yesterday and determined that it appeared to be a normal but pronounced inflammation from the vaccine.  According to mother this morning the area appeared much less reddened, much less swollen.  Patient reported to her that it is also much less painful today.
Age: 10.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pruritus, Injection site rash, Rash
Clinical narrative: Began itching below site of injection 8/28/07 during school.  School nurse noted rash (faint red, raised) below site, down left arm to wrist.  Last night (8/28) rash spread to left side of neck, chest & under arm.  Has applied Benadryl cream with minimal relief in itching.  No rash on rest of body.  No SOB . No hives.  (Left messages but no return calls for follow-up)
Age: 59.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Arthralgia, Body temperature increased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: temp 100.8, night sweats, swelling, redness, pain at site. Joint & muscle pain.No treatment other than Advil or Tylenol.
Age: 59.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Myalgia, Night sweats
Clinical narrative: temp 100.8, night sweats, swelling, redness, pain at site. Joint & muscle pain.No treatment other than Advil or Tylenol.
Age: 40.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain upper, Hyperhidrosis, Nervousness, Vomiting
Clinical narrative: Pt. experienced pain in stomach, sweating, nervousness, and vomitting.